Slingshot members are tracking this event:

Halozyme (HALO) announces termination of its development for PEGPH20

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks


Additional Information

Additional Relevant Details - Initiates Organizational Restructuring to Close Oncology Operations, Reducing Headcount by Approximately 55% -
- Board Authorizes Initiation of Capital Return with Share Repurchase Program for $350 Million Over Three Years -
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 04, 2019
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Pegph20